Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Derm CasesDermatology / Oral Medicine

Derm Cases · Dermatology / Oral Medicine

OSCE — recurrent oral aphthous ulcers: diagnosis, red-flag differentials, and stepwise therapy

An 8-minute OSCE station on classifying minor/major/herpetiform aphthae, excluding Behçet disease, coeliac disease and HIV, and counselling topical/systemic therapy including when to escalate.

8 minosce2 min readVerification in progress

Target exams

NEET-PGINICETUSMLEPLABMRCP
On this page
Study tools

Target exams

NEET-PGINICETUSMLEPLABMRCP
Prompt
An 8-minute OSCE station on classifying minor/major/herpetiform aphthae, excluding Behçet disease, coeliac disease and HIV, and counselling topical/systemic therapy including when to escalate.

Brief (to candidate)

A 24-year-old woman has recurrent painful oral ulcers for 3 years (3–5 episodes/year). Today she has two round ulcers on the non-keratinised buccal mucosa with erythematous halos. No genital ulcers, uveitis or GI symptoms reported. You have 8 minutes to classify the ulcers, exclude serious differentials, and plan management.

[10]

Candidate instructions

  1. Classify minor vs major vs herpetiform aphthous ulcers by size, number and healing.
  2. Differentiate from herpes, traumatic ulcer, Behçet, erythema multiforme, neutropenic/HIV-related ulcers.
  3. Screen for systemic associations (coeliac, IBD, Behçet, haematinic deficiency, HIV when indicated).
  4. Outline stepwise local then systemic therapy.
  5. Give safety-net advice (persistent ulcer >2–3 weeks → biopsy/referral).
[7]

Examiner checklist (mark each domain / 10)

DomainKey actions expected
RecognitionPainful round/oval ulcers on non-keratinised mucosa (buccal, labial, floor of mouth, soft palate, ventral tongue) with erythematous halo; typically spare heavily keratinised gingiva/hard palate unlike primary HSV[1][5]
ClassificationMinor (<10 mm, heal <2 weeks, no scar); major (>10 mm, heal weeks–months, may scar); herpetiform (crops of tiny ulcers that coalesce)[1][2]
Red-flag DDxBehçet (recurrent oral + genital ulcers ± uveitis/pathergy); EM (target lesions, drug/HSV trigger); HIV/neutropenia (atypical/large/persistent); squamous ca if solitary non-healing ulcer in smoker/older adult[6][5]
Work-upFBC, iron/B12/folate; consider coeliac serology if recurrent; HIV if risk/systemic clues; biopsy if atypical or >2–3 weeks non-healing[8][9]
Local therapyTopical corticosteroid (e.g. triamcinolone paste / betamethasone mouthwash as available), barrier/antiseptic rinses, analgesia; avoid triggering trauma/spicy foods during flares[1][5]
Systemic / specialShort oral corticosteroid for severe major RAS; colchicine/dapsone/thalidomide in refractory specialist settings (thalidomide: teratogenicity/neuropathy counselling)[7]
CommunicationExplain benign recurrent nature for simple RAS; document Behçet screen questions; safety-net non-healing ulcer

Model key actions

  • Classify as recurrent minor aphthous stomatitis if small, non-keratinised, self-healing lesions without systemic features.[1][5]
  • Explicitly screen Behçet (genital, eye, skin pathergy) and haematinics/coeliac when recurrent.[6][9]
  • Start potent topical steroid preparation for oral use; escalate only if major/refractory.[1]
  • Biopsy/refer any solitary non-healing ulcer.

Common errors

  • Calling every mouth ulcer herpes without site/vesicle history.
  • Missing Behçet red flags (genital/ocular).
  • Ignoring haematinic deficiency / coeliac work-up in frequent RAS.
  • Leaving a non-healing ulcer without biopsy pathway.
  • Using thalidomide without pregnancy prevention and neuropathy counselling.
[1] [6] [7] [9]
References8ShowHide
  1. [1]Gasmi Benahmed A, Noor S, Menzel A, et al. Oral Aphthous: Pathophysiology, Clinical Aspects and Medical Treatment. Archives of Razi Institute, 2021.PMID 35355774
  2. [2]Saikaly SK, Saikaly TS, Saikaly LE. Recurrent aphthous ulceration: a review of potential causes and novel treatments. The Journal of dermatological treatment, 2018.PMID 29278022
  3. [5]Stoopler ET, Villa A, Bindakhil M, et al. Common Oral Conditions: A Review. JAMA, 2024.PMID 38530258
  4. [6]Alibaz-Oner F, Direskeneli H. Update on the Diagnosis of Behçet Diagnostics (Basel), 2022.PMID 36611332
  5. [7]Jacobson JM, Greenspan JS, Spritzler J, et al. Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. The New England journal of medicine, 1997.PMID 9154767
  6. [8]Koparal M, Ege B, Dogan EI, et al. Evaluation of biochemical variables in patients with recurrent aphthous stomatitis. Journal of stomatology, oral and maxillofacial surgery, 2023.PMID 36162803
  7. [9]Sahin Y. Celiac disease in children: A review of the literature. World journal of clinical pediatrics, 2021.PMID 34316439
  8. [10]Lin D, Yang L, Wen L, et al. Crosstalk between the oral microbiota, mucosal immunity, and the epithelial barrier regulates oral mucosal disease pathogenesis Mucosal Immunol, 2021.PMID 34040155
PreviousOSCE — recurrent oral and genital ulcers: diagnose Behçet disease and protect the eyesDermatology / Rheumatology / OphthalmologyNextOSCE — Relapsing polychondritis: lobule-sparing ear, airway, steroidsDermatology / Rheumatology / ENT